## **Core Concept**
The neonatal screening programme for congenital hypothyroidism aims to detect elevated levels of thyroid-stimulating hormone (TSH) or low levels of thyroxine (T4) in newborns. This is crucial for early intervention to prevent intellectual disability and other complications. The timing and site of blood sample collection are critical for accurate results.

## **Why the Correct Answer is Right**
The correct answer involves collecting the blood sample from the heel (a peripheral site) between 48 to 72 hours of life. This timing allows for the detection of TSH levels that would be elevated in cases of congenital hypothyroidism, as the initial surge in TSH levels occurs shortly after birth, and by 48-72 hours, it stabilizes, providing a reliable indication of thyroid function. The heel prick is a standard method for neonatal screening as it is minimally invasive and can be performed with a small prick of blood.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Collecting the blood sample immediately after birth may not provide accurate TSH levels due to the physiological surge in TSH levels that occurs shortly after birth.
- **Option B:** Taking the sample before 24 hours may also not be ideal due to the TSH surge and potential for false negatives or inaccurate readings.
- **Option D:** Although the antecubital vein (Option D) could theoretically provide a blood sample, it is not practical or standard for neonatal screening due to the difficulty in accessing this vein in newborns without causing distress or requiring more invasive procedures.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that congenital hypothyroidism can lead to cretinism if not treated early. Early detection through neonatal screening allows for prompt initiation of thyroid hormone replacement therapy, which can prevent intellectual disability and other developmental issues. The heel prick test is a critical tool in this early detection process.

## **Correct Answer:** C. Heel, 48-72 hours.